 2
 
New horizon in heart failure: Investigational drug poised to change cardiology -- ScienceDailyQuicklink Submitted By Daniel Geery No comments
|
|
| Findings from the PARADIGM-HF trial, published simultaneously in the New England Journal of Medicine, "are extraordinarily powerful and compelling; they are destined to change the management of patients with chronic heart failure for years to come," said Milton Packer, MD, co-primary author of the study from University of Texas Southwestern Medical Center, in Dallas, Texas USA. |
| Rate It | View Ratings |
Daniel Geery Social Media Pages: 
In my run for U.S. Senate against Utah's Orrin Hatch, I posted many progressive ideas and principles that I internalized over the years. I'm leaving that site up indefinitely, since it describes what I believe most members of our species truly (more...)
OpEdNews depends upon can't survive without your help.
If you value this article and the work of OpEdNews, please either Donate or Purchase a premium membership.
To View Comments or Join the Conversation:
